GlaxoSmithKline Melanoma Drug Prolongs Patients’ Lives
Monday, June 4, 2012 - 00:50
in Health & Medicine
Results of a clinical trial, disclosed at a medical meeting in Chicago, showed that patients given trametinib lived longer than those receiving chemotherapy for advanced stages of the cancer.